@inproceedings{inproceedings, title  = {{Indirect Comparison of Efficacy of Zanubrutinib Versus Acalabrutinib in the Treatment of Relapsed/Refractory (R/R) Mantle Cell Lymphoma (MCL)}},

 url = {{}},

 year = {{2024}},

 month = {{1}},

 author = {{Shah B and Challagulla S and Xu S and Williams R and Ren S and Srivastava T and Gautam R and Yang K}},

 volume = {{24}},

 journal = {{CLINICAL LYMPHOMA MYELOMA & LEUKEMIA}},

 pages = {{S516-S517}},

 note = {{Accessed on 2024/12/26}}}